-
公开(公告)号:EP1527781B1
公开(公告)日:2008-07-23
申请号:EP03784565.8
申请日:2003-08-07
发明人: SATO, Fumie , ARAI, Iwao, c/o TAISHO PHARMACEUTICAL CO., LTD. , TAKANO, Norikazu, c/o TAISHO PHARMACEUTICAL CO.Ltd , TANAMI, Tohru, c/o TAISHO PHARMACEUTICAL CO., LTD. , YAGI, Makoto, c/o TAISHO PHARMACEUTICAL CO., LTD.
IPC分类号: A61K31/5575 , A61P17/04
CPC分类号: A61K31/5575 , Y10S514/861 , Y10S514/887
摘要: A drug for the prevention of or treatments for itching symptoms which contains as an active ingredient a prostaglandin derivative represented by the formula [1]: [1] (wherein X and X are different and each represents hydrogen, halogeno, or hydroxy), a pharmaceutically acceptable salt of the derivative, or a hydrate of the derivative.
摘要翻译: 一种用于预防或治疗瘙痒症状的药物,其含有式[1]所示的前列腺素衍生物作为活性成分:[1](式中,X 1和X 2不同,表示氢,卤素 ,或羟基),衍生物的药学上可接受的盐或衍生物的水合物。
-
公开(公告)号:EP1527781A1
公开(公告)日:2005-05-04
申请号:EP03784565.8
申请日:2003-08-07
发明人: SATO, Fumie , ARAI, Iwao, c/o TAISHO PHARMACEUTICAL CO., LTD. , TAKANO, Norikazu, c/o TAISHO PHARMACEUTICAL CO.Ltd , TANAMI, Tohru, c/o TAISHO PHARMACEUTICAL CO., LTD. , YAGI, Makoto, c/o TAISHO PHARMACEUTICAL CO., LTD.
IPC分类号: A61K31/5575 , A61P17/00 , A61P17/04 , A61P27/02
CPC分类号: A61K31/5575 , Y10S514/861 , Y10S514/887
摘要: A pharmaceutical preparation for preventing or treating pruritic symptoms which contains as an effective ingredient a prostaglandin derivative represented by formula [1]
wherein X 1 and X 2 which are different from each other represent a hydrogen atom, a halogen atom or a hydroxyl group;
Y is an ethylene group, a vinylene group or an ethynylene group; Z is the formula
(CH 2 ) k A(CH 2 ) h B(CH 2 ) q ,
(CH 2 ) k A(CH 2 ) r A'(CH 2 ) t ,
(CH 2 ) k B(CH 2 ) h B'(CH 2 ) q
or
(CH 2 ) k-1 B'(CH 2 ) q-1 A'
wherein k is an integer of 1 to 4, h is an integer of 0 to 4, q is an integer 1 to 4, r is an integer of 0 to 4, and t is an integer of 0 to 2;
A and A' which may be the same or different represent an ethylene group, a vinylene group or an ethynylene group;
B and B' which may be the same or different represent an oxygen atom or a group represented by the formula S(O) u wherein u is an integer of 0 to 2;
W 1 is a hydroxyl group, a C 1-10 alkyloxy group, a C 3-10 cycloalkyloxy group, an aryloxy group or an arylalkyloxy group;
W 2 is a C 1-10 alkyl group, a C 2-10 alkenyl group, a C 2-10 alkynyl group, a C 3-10 cycloalkyl group, a C 1-5 alkyl group substituted by C 3-10 cycloalkyl group(s), or a group represented by the formula
wherein W 4 is a C 1-10 alkyl group, a C 2-10 alkenyl group, a C 2-10 alkynyl group or a C 1-5 alkyl group substituted by C 3-10 cycloalkyl group(s); v is an integer of 0 to 4;
W 3 is a hydrogen atom or a methyl group, or W 3 when taken together with W 2 and the adjacent carbon atom forms a C 3-10 cycloalkyl group; m is 0 or 1, a pharmaceutically acceptable salt thereof or a hydrate thereof.摘要翻译: 一种用于预防或治疗瘙痒症状的药物制剂,其含有式[1]所示的前列腺素衍生物作为有效成分,其中彼此不同的X 1和X 2表示氢原子,卤素原子或羟基; Y是亚乙基,亚乙烯基或亚乙炔基; Z是式(CH 2)k A(CH 2)h B(CH 2)q,(CH 2)k A(CH 2) 1B'(CH 2)q-1A'式中,k为1〜4的整数,h为0〜4的整数,q为1〜4的整数,r为0〜4的整数,t为整数 0到2; A和A'可以相同或不同,表示亚乙基,亚乙烯基或亚乙炔基; B和B'可以相同或不同,表示氧原子或由式S(O)u表示的基团,其中u是0-2的整数; W1是羟基,C1-10烷氧基,C3-10环烷氧基,芳氧基或芳基烷氧基; W2为C1-10烷基,C2-10烯基,C2-10炔基,C3-10环烷基,C3-10环烷基取代的C1-5烷基或基团 由下式表示:其中W4是C1-10烷基,C2-10链烯基,C2-10炔基或被C3-10环烷基取代的C1-5烷基; v是0至4的整数; W3是氢原子或甲基,或者W3与W2一起形成并且相邻的碳原子形成C3-10环烷基; m是0或1,其药学上可接受的盐或其水合物。
-